PATENT CLAIM ANALYSIS

Application Number: 15755362
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-08
Patent Classification: ["530", "300000"]

Abstract:
The proposed drug relates to medicine and veterinary applications, in particular, as a means for effective control of acute and/or chronic pain, and may be used in emergency medicine for the treatment of acute and/or chronic pain, including the late stages of cancer. The stated means is based on a compound for preventing and/or treating acute or chronic pain in a subject, including an analgesic peptide having an amino acid sequence H-Tyr-D-Arg-Phe-Gly-NH2 or an amino acid sequence H-Tyr-D-Arg-Phe-Sar-OH. Also, a method of use/administration of the compound for the prevention and/or treatment of acute and/or chronic pain is disclosed.

Claim (Index 12):
The composition according to  claim 1 , wherein the liquid form for nasal administration comprises in mass % the following: Sodium acetate 0.01-0.2 Sodium chlorite 0-1\u2002\u2009 Mannitol 0-1.5 Glycine 0-1.5 Tetrapeptide Substance 0.01-5\u2003\u2003 Metacresol 0-0.5 Water To 100 pH To 4.5-6

Metadata:
- Claim Count in Document: 17.0
- Percentile: 93.0
- Lexical Diversity: 1.87719
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10068905', '11440727', '11079632', '12786686', '11938771']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7015215490398903
- 35 USC 102 Novelty (BERT): 0.5092882636974567
- Combined Prediction Score: 0.682298220505647
- Mean Citation Score: 244.894312
- Max Citation Score: 252.8824
- Similarity Product: 157.39550946316714

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test